In mice, Phd2 deletion in myeloid cells (LysM-Cre), in all T-cell populations (CD4-Cre) or in B-cells (CD19-Cre) had no effect on tumours from LLC cells [96]. The gene discussed is CD4; the disease is neoplasm.